DECISION OF THE EEA JOINT COMMITTEE No 62/2024

of 15 March 2024

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1597]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,

Whereas:

(1)

Commission Implementing Regulation (EU) 2023/2088 of 28 September 2023 approving reaction mass of N,N-didecyl-N-(2-hydroxyethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-hydroxyethoxy)ethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-N-methylammonium propionate as an active substance for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement.

(2)

Commission Implementing Regulation (EU) 2023/2596 of 21 November 2023 renewing the approval of propiconazole as an active substance for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (2) is to be incorporated into the EEA Agreement.

(3)

Commission Implementing Regulation (EU) 2023/2620 of 24 November 2023 approving sulfur dioxide generated from sulfur by combustion as an active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (3) is to be incorporated into the EEA Agreement.

(4)

Commission Implementing Regulation (EU) 2023/2643 of 27 November 2023 approving formic acid as an existing active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (4) is to be incorporated into the EEA Agreement.

(5)

Commission Implementing Decision (EU) 2023/2622 of 24 November 2023 not approving silver zinc zeolite as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (5) is to be incorporated into the EEA Agreement.

(6)

Commission Implementing Decision (EU) 2023/2630 of 27 November 2023 on the unresolved objections regarding the conditions for granting an authorisation for the product Procalx in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (6) is to be incorporated into the EEA Agreement.

(7)

Commission Implementing Decision (EU) 2023/2648 of 27 November 2023 not approving silver zeolite as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (7) is to be incorporated into the EEA Agreement.

(8)

Commission Implementing Decision (EU) 2023/2672 of 27 November 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product family INTEROX Biocidal Product Family 2 raised in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (8) is to be incorporated into the EEA Agreement.

(9)	Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzzzzu (Commission Implementing Decision (EU) 2023/2386) of Chapter XV of Annex II to the EEA Agreement:

‘12zzzzzzzzzv.

32023 R 2088: Commission Implementing Regulation (EU) 2023/2088 of 28 September 2023 approving reaction mass of N,N-didecyl-N-(2-hydroxyethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-hydroxyethoxy)ethyl)-N-methylammonium propionate and N,N-didecyl-N-(2-(2-(2-hydroxyethoxy)ethoxy)ethyl)-N-methylammonium propionate as an active substance for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 241, 29.9.2023, p. 99).

12zzzzzzzzzw.

32023 R 2596: Commission Implementing Regulation (EU) 2023/2596 of 21 November 2023 renewing the approval of propiconazole as an active substance for use in biocidal products of product-type 8 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2023/2596, 22.11.2023).

12zzzzzzzzzx.

32023 R 2620: Commission Implementing Regulation (EU) 2023/2620 of 24 November 2023 approving sulfur dioxide generated from sulfur by combustion as an active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2023/2620, 27.11.2023).

12zzzzzzzzzy.

32023 D 2622: Commission Implementing Decision (EU) 2023/2622 of 24 November 2023 not approving silver zinc zeolite as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2023/2622, 28.11.2023).

12zzzzzzzzzz.

32023 D 2630: Commission Implementing Decision (EU) 2023/2630 of 27 November 2023 on the unresolved objections regarding the conditions for granting an authorisation for the product Procalx in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2023/2630, 29.11.2023).

12zzzzzzzzzza.

32023 R 2643: Commission Implementing Regulation (EU) 2023/2643 of 27 November 2023 approving formic acid as an existing active substance for use in biocidal products of product-types 2, 3, 4 and 5 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2023/2643, 28.11.2023).

12zzzzzzzzzzb.

32023 D 2648: Commission Implementing Decision (EU) 2023/2648 of 27 November 2023 not approving silver zeolite as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2023/2648, 29.11.2023).

12zzzzzzzzzzc.

32023 D 2672: Commission Implementing Decision (EU) 2023/2672 of 27 November 2023 on the unresolved objections regarding the terms and conditions of the authorisation of the biocidal product family INTEROX Biocidal Product Family 2 raised in accordance with Article 36 of Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L, 2023/2672, 29.11.2023).’

Article 2

The texts of Implementing Regulations (EU) 2023/2088, (EU) 2023/2596, (EU) 2023/2620 and (EU) 2023/2643 and Implementing Decisions (EU) 2023/2622, (EU) 2023/2630, (EU) 2023/2648 and (EU) 2023/2672 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.

Article 3

This Decision shall enter into force on 16 March 2024, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.

Done at Brussels, 15 March 2024.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

(1) OJ L 241, 29.9.2023, p. 99.

(2) OJ L, 2023/2596, 22.11.2023.

(3) OJ L, 2023/2620, 27.11.2023.

(4) OJ L, 2023/2643, 28.11.2023.

(5) OJ L, 2023/2622, 28.11.2023.

(6) OJ L, 2023/2630, 29.11.2023.

(7) OJ L, 2023/2648, 29.11.2023.

(8) OJ L, 2023/2672, 29.11.2023.

(*1) No constitutional requirements indicated.